Activities of nonlysosomal proteolytic systems in skeletal and cardiac muscle during burn-induced hypermetabolism

Journal of Burn Care and Research

Volumn 35, Issue 4, 2014, Pages 319-327

  Wong, Yee M ^a   La Porte, Heather M ^a   Szilagyi, Andrea ^a   Bach, Harold H ^a   Li, Ke He ^a   Kennedy, Richard H ^a   Gamelli, Richard L ^a   Shankar, Ravi ^a   Majetschak, Matthias ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALPAIN; CASPASE 3; CASPASE 6; CASPASE 7; CASPASE 8; CASPASE 9; INTERLEUKIN 1BETA CONVERTING ENZYME; PEPTIDASE; CASPASE; PROTEASOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BURN; BURN INDUCED HYPERMETABOLISM; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HEART MUSCLE; HEART STRESS; HYPERMETABOLISM; MALE; NONHUMAN; NONLYSOSOMAL PROTEOLYTIC SYSTEM; PECTORAL MUSCLE; PROTEIN DEGRADATION; PROTEIN METABOLISM; RAT; RESTING ENERGY EXPENDITURE; SOLEUS MUSCLE; ANIMAL; ENERGY METABOLISM; METABOLISM; SKELETAL MUSCLE; SPRAGUE DAWLEY RAT;

ANIMALS; BODY WEIGHT; BURNS; CALPAIN; CASPASES; ENERGY METABOLISM; MALE; MODELS, ANIMAL; MUSCLE, SKELETAL; MYOCARDIUM; PROTEASOME ENDOPEPTIDASE COMPLEX; RATS, SPRAGUE-DAWLEY;

EID: 84903821147     PISSN: 1559047X     EISSN: 15590488     Source Type: Journal    
DOI: 10.1097/BCR.0000000000000060     Document Type: Article

References (58)

1. Pereira C, Murphy K, Jeschke M, Herndon DN. Post burn muscle wasting and the effects of treatments. Int J Biochem Cell Biol 2005;37:1948-61. (Pubitemid 41206813)
2. Hart DW, Wolf SE, Chinkes DL, et al. Determinants of skeletal muscle catabolism after severe burn. Ann Surg 2000;232:455-65.
3. Garcia de Lorenzo y Mateos A, Ortiz Leyba C , Sanchez SM. Guidelines for specialized nutritional and metabolic support in the critically-ill patient: update. Consensus SEMICYUC-SENPE: critically-ill burnt patient. Nutr Hosp 2011;26(Suppl 2):59-62.
4. Williams FN, Herndon DN, Jeschke MG. The hypermetabolic response to burn injury and interventions to modify this response. Clin Plast Surg 2009;36:583-96.
5. Porter C, Hurren NM, Herndon DN, Børsheim E. Whole body and skeletal muscle protein turnover in recovery from burns. Int J Burns Trauma 2013;3:9-17.
6. Matsuda T, Clark N, Hariyani GD, Bryant RS, Hanumadass ML, Kagan RJ. The effect of burn wound size on resting energy expenditure. J Trauma 1987;27:115-8. (Pubitemid 17055741)
7. Jeschke MG, Gauglitz GG, Kulp GA, et al. Long-term persistance of the pathophysiologic response to severe burn injury. PLoS One 2011;6:e21245.
8. Wilmore DW, Aulick LH, Mason AD, Pruitt BA Jr. Influence of the burn wound on local and systemic responses to injury. Ann Surg 1977;186:444-58. (Pubitemid 8197676)
9. Porter C, Herndon DN, Sidossis LS, Børsheim E. The impact of severe burns on skeletal muscle mitochondrial function. Burns 2013;39:1039-47.
10. Tuvdendorj D,Chinkes DL,Zhang XJ,et al Long-term oxandrolone treatment inc reases muscle protein net deposition via improving amino acid utilization in pediatric patients 6 months after burn injury Surgery 2011 149 645-53.
11. Hart DW, Wolf SE, Ramzy PI, et al. Anabolic effects of oxandrolone after severe burn. Ann Surg 2001;233:556-64. (Pubitemid 32234955)
12. Suman OE, Mlcak RP, Herndon DN. Effects of exogenous growth hormone on resting pulmonary function in children with thermal injury. J Burn Care Rehabil 2004;25:287-93. (Pubitemid 38637787)
13. Herndon DN, Ramzy PI, DebRoy MA, et al. Muscle protein catabolism after severe burn: effects of IGF-1/IGFBP-3 treatment. Ann Surg 1999;229:713-20; discussion 720-2.
14. Meyer NA, Barrow RE, Herndon DN. Combined insulin-like growth factor-1 and growth hormone improves weight loss and wound healing in burned rats. J Trauma 1996;41:1008-12. (Pubitemid 127496270)
15. Strock LL, Singh H, Abdullah A, Miller JA, Herndon DN. The effect of insulin-like growth factor I on postburn hypermetabolism. Surgery 1990;108:161-4. (Pubitemid 20255446)
16. Biolo G, Fleming RY, Maggi SP, Nguyen TT, Herndon DN, Wolfe RR. Inverse regulation of protein turnover and amino acid transport in skeletal muscle of hypercatabolic patients. J Clin Endocrinol Metab 2002;87:3378-84. (Pubitemid 34816392)
17. Fang CH, Tiao G, James H, Ogle C, Fischer JE, Hasselgren PO. Burn injury stimulates multiple proteolytic pathways in skeletal muscle, including the ubiquitin-energy-dependent pathway. J Am Co ll Surg 1995;180:161-70.
18. Fang CH, Li BG, Wray CJ, Hasselgren PO. Insulin-like growth factor-I inhibits lysosomal and proteasome-dependent proteolysis in skeletal muscle after burn injury. J B urn Care Rehabil 2002;23:318-25. (Pubitemid 35014776)
19. Fang CH, Li BG, Fischer DR, et al. Burn injury upregulates the activity and gene expression of the 20 S proteasome in rat skeletal muscle. Clin Sci (Lond) 2000;99:181-7.
20. Duan H, Chai J, Sheng Z, et al. Effect of burn injury on apoptosis and expression of apoptosis-related genes/proteins in skeletal muscles of rats. Apoptosis 2009;14:52-65.
21. Yasuhara S, Perez ME, Kanakubo E, et al. Skeletal muscle apoptosis after burns is associated with activation of proapoptotic signals. Am J Physiol Endocrinol Metab 2000;279:E1114-21.
22. Yasuhara S, Kanakubo E, Perez ME, et al. The 1999 Moyer award. Burn injury induces skeletal muscle apoptosis and the activation of caspase pathways in rats. J Burn Care Rehabil 1999;20:462-70. (Pubitemid 30007824)
23. Chai J, Wu Y, Sheng Z. The relationship between skeletal muscle proteolysis and ubiquitin-proteasome proteolytic pathway in burned rats. Burns 2002;28:527-33. (Pubitemid 36153196)
24. Lowell BB , Ruderman NB, Goodman MN. Evidence that lysosomes are not involved in the degradation of myofibrillar proteins in rat skeletal muscle. Biochem J 1986;234:237-40. (Pubitemid 16053683)
25. Wildenthal K, Wakeland JR, Ord JM, Stull JT. Interference with lysosomal proteolysis fails to reduce cardiac myosin degradation. Biochem Biophys Res Commun 1980;96:793-8. (Pubitemid 11198406)
26. Goll DE, Neti G, Mares SW, Thompson VF. Myofibrillar protein turnover: the proteasome and the calpains. J Anim Sci 2008;86(14 Suppl):E19-35.
27. Walker HL, Mason AD Jr. A standard animal burn. J Trauma 1968;8:1049-51.
28. Baker TA, Geng Q, Romero J, Picken MM, Gamelli RL, Majetschak M. Prolongation of myocardial viability by proteasome inhibition during hypothermic organ preservation. Biochem Biophys Res Commun 2010;401:548-5 3.
29. Geng Q, Romero J, Saini V, et al. A subset of 26S proteasomes is activated at critically low ATP concentrations and contributes to myocardial injury during cold ischemia. Biochem Biophys Res Commun 20 09;390:1136-41.
30. Majetschak M, Patel MB, Sorell LT, Liotta C, Li S, Pham SM. Cardiac proteasome dysfunction during cold ischemic storage and reperfusion in a murine heart transplantation model. Biochem Biophys Res Commun 2008;365:882-8. (Pubitemid 350234876)
31. Majetschak M,Sorell LT Immunological methods to quantify and characterize proteasome complexes: development and application J Immunol Methods 2008 334 91-103.
32. Gribble FM, Loussouarn G, Tucker SJ, Zhao C, Nichols CG, Ashcroft FM. A novel method for measurement of submembrane ATP concentration. J Biol Chem 2000;275:30046-9.
33. Ando T, Imamura H, Suzuki R, et al. Visualization and measurement of ATP levels in living cells replicating hepatitis C virus genome RNA. PLoS Pathog 2012;8:e1002561.
34. Beer M, Seyfarth T, Sandstede J, et al. Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spect roscopy. J Am Coll Cardiol 2002;40:1267-74.
35. Bottomley PA, Atalar E, Weiss RG. Human cardiac high-energy phosphate metabolite concentrations by 1D-resolved NMR spectroscopy. Magn Reson Med 1996;35:664-70.
36. Köstler H, Landschütz W, Koeppe S, et al. Age and gender dependence of human cardiac phosphorus metabolites determined by SLOOP 31P MR spectroscopy. Magn Reson Med 2006;56:907-11. (Pubitemid 44477674)
37. Jones LK. Resting energy expe nditure in patients with thermal injuries. JPEN J Parenter Enteral Nutr 1993;17:94-6.
38. Carlson DE, Cioffi WG Jr., Mason AD Jr., McManus WF, Pruitt BA Jr. Resting energy expenditure in patients with thermal injuries. Surg Gynecol Obstet 1992;174:270-6.
39. Majetschak M, W aydhas C. Infection, bacteremia, sepsis and the sepsis syndrome-metabolic alterations, hypermetabolism, and cellular alterations. In: Baue AE, Faist E, Fry DE, editors: Multiple organ failure: pathophysiology, prevention, and therapy. New York: Spring er; 2000. p. 101-7.
40. Tan Y, Peng X, Wang F, You Z, Dong Y, Wang S. Effects of tumor necrosis factor-alpha on the 26S proteasome and 19S regulator in skeletal muscle of severely scalded mice. J Burn Care Res 2006;27:226-33. (Pubitemid 43970330)
41. Majetschak M. Regulation of the proteasome by ATP: implications for ischemic myocardial injury and donor heart preservation. Am J Physiol Heart Circ Physiol 2013;305:H267-78.
42. Sprague DB, Gadian DG, Williams SR, Proctor E, Goode AW. Intracellular metabolites in rat muscle following trauma: a 31P and 1H nuclear magnetic resonance study. J R Soc Med 1987;80:495-8.
43. Lee HY, Kaneki M, Andreas J, Tompkins RG, Martyn JA. Novel mitochondria-targeted antioxidant peptide ameliorates burn-induced apoptosis and endoplasmic reticulum stress in the skeletal mus cle of mice. Shock 2011;36:580-5.
44. Fan TJ, Han LH, Cong RS, Liang J. Caspase family proteases and apoptosis. Acta Biochim Biophys Sin (Shanghai) 2005;37:719-27. (Pubitemid 44890981)
45. Du J, Wang X, Miereles C, et al. Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions. J Clin Invest 2004;113:115-23. (Pubitemid 38541638)
46. Belizario JE, Alves J, Garay-Malpartida M, Occhiucci JM. Coupling caspase cleavage and proteasomal degradation of proteins carrying PEST motif. Curr Protein Pept Sci 2008;9:210-20. (Pubitemid 351997837)
47. Rogers S, Wells R, Rechsteiner M. Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science 1986;234:364-8. (Pubitemid 17181385)
48. Fang CH, Li BG, Tiao G, Wang JJ, Fischer JE, Hasselgren PO. The molecular regulation of protein breakdown following burn injury is different in fast-and slow-twitch skeletal muscle. Int J Mol Med 1998;1:163-9.
49. Cao W, Xie YH, Li XQ, et al. Burn-induced apoptosis of cardiomyocytes is survivin dependent and regulated by PI3K/Akt, p38 MAPK and ERK pathways. Basic Res Cardiol 2011;106:1207-20.
50. Zhang JP, Ying X, Liang WY, et al. Apoptosis in cardiac myocytes during the early stage after severe burn. J Trauma 2008;65:401-8; discussion 408.
51. Carlson DL, Horton JW. Cardiac molecular signaling after burn trauma. J Burn Care Res 2006;27:669-75. (Pubitemid 44450639)
52. Williams FN, Herndon DN, Suman OE, et al. Changes in cardiac physiology after severe burn injury. J Burn Care Res 2011;32:269-74.
53. Depre C,Wang Q,Yan L,et al Activation of the cardiac proteasome during pressure overload promotes ventricular hypertrophy Circulation 2006 114 1821-8. (Pubitemid 44673357)
54. Warren SA, Briggs LE, Zeng H, et al. Myosin light chain phosphorylation is critical for adaptation to cardiac stress. Circulation 2012;126:2575-88.
55. Ma Y, Chen Y, Yang Y, et al. Proteasome inhibition attenuates heart failure during the late stages of pressure overload through alterations in collagen expression. Biochem Pharmacol 2013;85:223-33.
56. Mitch WE, Price SR. Mechanisms activating proteolysis to cause muscle atrophy in catabolic conditions. J Ren Nutr 2003;13:149-52. (Pubitemid 38368774)
57. McIlwain DR, Berger T, Mak TW. Caspase functions in cell death and disease. Cold Spring Harb Perspect Biol 2013;5:a008656.
58. Bailey JL. Insulin resistance and muscle metabolism in chronic kidney disease. ISRN Endocrinol 2013;2013:329606.pag 328-336